MedTech companies and enterprises are integral to the MedTech ecosystem, responsible for developing and providing products and services that directly benefit patients, caregivers, and clinicians. These industry players possess a deep understanding of the regulatory and business realities involved in bringing their products to market, as well as an awareness of the unmet needs of clinicians, institutions, and end-users.
Researchers and innovators are experts in technology and possess innovative ideas that can transform clinical practice, leading to improved patient outcomes. Despite the potential benefits of collaboration between university innovators and industry, creating strong, enduring relationships that yield sustained outcomes can be challenging.
Please join us for morning tea as Dr Daneh Turner from GE Healthcare and Stuart Anderson from the Medical Technology Association of Australia, share their insights on building relationships and forging successful partnerships with university innovators.
Our presenters
Dr Daneh Turner | GE Healthcare, Regional Research Manager, Australia and New Zealand
Stuart Anderson | CTC-M Program Manager, Medical Technology Association of Australia
Dr Ian Goon | Head of Strategy and Innovation, Tyree IHealthE (session moderator)
REGISTER HERE
The morning tea sessions are a chance to get together and hear experiences and lessons from a range of speakers, meet the Tyree IHealthE team, and have plenty of time for questions and discussion. Please bring a cup of tea and we will supply the cake. Everyone is welcome to attend.
Bios
Dr Daneh Turner is the Regional Research Manager for Australia and New Zealand at GE Healthcare. Her role is to facilitate partnerships with world class academic institutions and industry partners to support research and development. Prior to working at GE Healthcare, Dr Turner worked at Macquarie University as a Senior Lecturer in the field of orthopaedic biomechanics; and previous to that as a partner and Biomedical Specialist in a consulting firm. Working closely with clinical and industry partners, she and her team used advanced computational modelling techniques, imaging technologies and clinical research methods to answer questions related to joint arthroplasty and surgical reconstruction, and improvements in orthopaedic implant design.
Dr Turner has undergraduate training as a mechanical engineer and postgraduate training in biomedical engineering from UNSW.
Stuart Anderson supports the Medical Technology Association of Australia (MTAA) with delivering the Clinical Translation and Commercialisation – Medtech (CTC-M) Program on behalf of MTPConnect as part of a broader industry development and technology commercialisation initiative at the MTAA. He is passionate about growing Australia’s medical device innovation ecosystem toward the goal of improved patient otucomes across research translation, rapid growth start-ups and our nascent sovereign manufacturing capability by enhancing connections with global medical device companies and disciplined investors. He brings to this role a blend of equity capital market, including venture capital and private equity, strategic insights, innovation consulting, product development and entrepreneurial experiences.
Session moderator
Dr Ian Goon has a background in scientific research, developing nano-materials for biosensing applications and subsequently spent 4 years in a commercially focused-role as a strategy consultant with The Boston Consulting Group in Southeast Asia. Ian co-founded a health technology startup focused on building digital tools for healthcare research projects, prior to joining Tyree IHealthE. His work included leading the development and implementation of technology platforms for the South Asia Biobank (South Asia and UK) and the SG100K population health study in Singapore. Ian holds a BEng (Chemical) and Ph.D from UNSW and obtained an MPhil in Bioscience Enterprise from the University of Cambridge as a Chevening scholar.